| 000 | 01733 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513160940.0 | ||
| 264 | 0 | _c19990210 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0009-7322 | ||
| 024 | 7 |
_a10.1161/01.cir.99.1.73 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGreinacher, A | |
| 245 | 0 | 0 |
_aRecombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. _h[electronic resource] |
| 260 |
_bCirculation _c |
||
| 300 |
_a73-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 |
_aHemorrhage _xepidemiology |
| 650 | 0 | 4 |
_aHeparin _xadverse effects |
| 650 | 0 | 4 | _aHirudin Therapy |
| 650 | 0 | 4 |
_aHirudins _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVölpel, H | |
| 700 | 1 | _aJanssens, U | |
| 700 | 1 | _aHach-Wunderle, V | |
| 700 | 1 | _aKemkes-Matthes, B | |
| 700 | 1 | _aEichler, P | |
| 700 | 1 | _aMueller-Velten, H G | |
| 700 | 1 | _aPötzsch, B | |
| 773 | 0 |
_tCirculation _gvol. 99 _gno. 1 _gp. 73-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.99.1.73 _zAvailable from publisher's website |
| 999 |
_c9846226 _d9846226 |
||